Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment.

Cancer science - 1 Oct 2009

Jida Masaru, Toyooka Shinichi, Mitsudomi Tetsuya, Takano Toshimi, Matsuo Keitaro, Hotta Katsuyuki, Tsukuda Kazunori, Kubo Takafumi, Yamamoto Hiromasa, Yamane Masaomi, Oto Takahiro, Sano Yoshifumi, Kiura Katsuyuki, Yatabe Yasushi, Ohe Yuichiro, Date Hiroshi, Miyoshi Shinichiro

Abstract excerpt

We examined the diagnostic accuracy of the cumulative smoking dose for identifying the epidermal growth factor receptor (EGFR) exon 19 deletion and L858R mutation among Japanese patients with non-small-cell lung cancer (NSCLC). EGFR mutations in exon 19 and exon 21 were determined in 1001 NSCLC p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gefitinib

Share to Kaplan-Meier Estimate

Share to Quinazolines

Share to ROC Curve

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 19650855
DOI: 10.1111/j.1349-7006.2009.01273.x
PMCID: PMC11158181

Genes

EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19650855-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment.PMID 19650855Read ↗

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study.Semantic proximity Read ↗

Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.Semantic proximity Read ↗

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.Semantic proximity Read ↗

Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.Semantic proximity Read ↗

Nomogram prediction for epidermal growth factor receptor mutation and subtypes in patients with non-small cell lung cancerSemantic proximity Read ↗

Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations.Semantic proximity Read ↗

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.Semantic proximity Read ↗

Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer.Semantic proximity Read ↗

Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by immunohistochemistry.Semantic proximity Read ↗

Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.Semantic proximity Read ↗

Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.Semantic proximity Read ↗

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.